Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Severe asthma is characterized by different endotypes driven by complex pathologic mechanisms. In most patients with both allergic and non-allergic asthma, predominant eosinophilic airway inflammation is present. Given the central role of eosinophilic inflammation in the pathophysiology of most cases of severe asthma and considering that severe eosinophilic asthmatic patients respond partially or poorly to corticosteroids, in recent years, research has focused on the development of targeted anti-eosinophil biological therapies; this review will focus on the unique and particular biology of the eosinophil, as well as on the current knowledge about the pathobiology of eosinophilic inflammation in asthmatic airways. Finally, current and prospective anti-eosinophil therapeutic strategies will be discussed, examining the reason why eosinophilic inflammation represents an appealing target for the pharmacological treatment of patients with severe asthma.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496162 | PMC |
| http://dx.doi.org/10.3390/biomedicines10092181 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prognostic role of the baseline neutrophil‒eosinophil ratio in cancer patients: a meta-analysis and systematic review.
World J Surg Oncol
September 2025
Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Background: Inflammation impacts the prognosis of numerous types of tumors. Inflammatory indicators such as the neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and neutrophil-to-eosinophil ratio (NER) have emerged as potential prognostic markers and are closely correlated with the outcomes of cancer patients. However, the connection between NER and cancer prognosis remains incompletely understood.
View Article and Find Full Text PDFAssociations between depression severity and immune activity in youth patients.
J Affect Disord
September 2025
Department of Clinical Psychology and Psychotherapy for Children and Adolescents, Friedrich-Alexander-Universität Erlangen, Nürnberg, Germany; German Center for Mental Health (DZPG), Tübingen, Germany.
Numerous clinical and epidemiological studies have demonstrated altered immune activity in adult depression patients, yet comparable data in youth are scarce. This study investigated the relationship between depression severity and peripheral immune measures in a clinical sample of children and adolescents. We analyzed 1198 blood samples from 819 patients (age range: 8-18 years) diagnosed with mild, moderate, or severe depression disorder using ICD-10 criteria.
View Article and Find Full Text PDFEmerging systemic treatments for asthma and allergic diseases: New tricks, same dog?
J Allergy Clin Immunol Pract
September 2025
Associate Professor of Medicine, Medical Director of Clinical Asthma Research, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center. Electronic address:
Asthma and allergic diseases are heterogeneous conditions driven by complex immunological pathways, with type 2 (T2) inflammation being a key but not exclusive component. Advances in immunology have spurred interest in a breadth of mechanisms and innovative therapeutic strategies, including novel targets, extended dosing intervals, and combined-target therapies. This clinical commentary provides a critical overview of ongoing clinical trials and emerging evidence supporting the use of these therapies in asthma and other allergic conditions.
View Article and Find Full Text PDFThree Biologic-Naïve Patients with Allergic Bronchopulmonary Aspergillosis Showing Significant Clinical Improvement with Tezepelumab.
J Asthma Allergy
August 2025
Division of Respiratory Medicine, Department of Internal Medicine, Shiga University of Medical Science, Otsu, Japan.
Allergic bronchopulmonary aspergillosis is characterized by hypersensitivity to spp. and often causes intractable asthma. Studies have been conducted on biologics administered to patients with allergic bronchopulmonary aspergillosis; however, treatment may not always be successful.
View Article and Find Full Text PDFTraffic-emitted ultrafine particles disrupt macrophage efferocytosis and resolution of allergic lung inflammation.
J Allergy Clin Immunol
September 2025
Pulmonary and Critical Care Medicine, Department of Internal Medicine, Brigham and Women's Hospital and Harvard Medical School; Boston, MA 02115, USA. Electronic address:
Background: Particulate matter (PM) in air pollution is a major health concern. PM includes ultrafine particles (UFPs - PM, particles of ≤ 0.1μm), which can evoke lung inflammation.
View Article and Find Full Text PDF